| Name | Title | Contact Details |
|---|
Acucela is a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases impacting millions of individuals worldwide. Acucela currently has the following candidates in development with Otsuka Pharmaceutical: emixustat hydrochloride for GA associated with dry AMD based on Acucela’s proprietary visual cycle modulation; and OPA-6566 for ocular hypertension and glaucoma.
Galderma Laboratories, L.P. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Fort Worth, TX. To find more information about Galderma Laboratories, L.P., please visit www.galderma.com
Oxford Health Plans, Inc. is a healthcare company providing health benefit plans primarily in New York, New Jersey and Connecticut. Its product line includes its health maintenance organization plans, exclusive provider organization plans,
Fallon Medicca is a Tinton Falls, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Arizona Medical Spine Inst is a Phoenix, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.